Delivery Order SPE2DB20D7059-SPE2DB25FQMJ2
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $33,553.93 to AmerisourceBergen Drug Corp for Lupron Depot-Ped 30 mg 3-month kits, a specialty pharmaceutical product used in pediatric endocrinology treatment. This firm fixed-price delivery order, awarded on July 24, 2025, with an ultimate completion date of July 25, 2025, represents a competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the supply of Lupron Depot-Ped 11.25 mg kits, a pharmaceutical product used in medical treatment programs. The potential value of this delivery order is $4,095.71, with a completion date of December 21, 2023. Amerisourcebergen Drug Corp is a prime contractor that has received numerous...
- The Defense Logistics Agency (DLA) awarded a $17,899.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lupron Depot 3.75 mg kits, with an ultimate completion date of July 22, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a $41,784 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Lupron Depot-Ped 11.25 mg injections to be administered over a three month period. As the prime contractor, Amerisourcebergen will deliver the injections from its Conshohocken, Pennsylvania facility to support the Defense Logistics Agency's medical supply needs. No subcontractors or set aside designations were identified. The delivery order was issued on September 6, 2023...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at $21,449.68 to Amerisourcebergen Drug Corporation for the supply of Lupron Depot-Ped, an injectable drug used to treat pediatric endocrine conditions. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with all supplies to be delivered between July 20-21, 2023. The award was made using the Defense Logistics Agency's Pharmaceutical Prime Vendor contract,...
- The Defense Logistics Agency awarded a delivery order valued at $9,014.39 to AmerisourceBergen Drug Corp for the supply of Lupron Depot 3.75 mg kits. This competitively awarded, firm fixed-price contract has an ultimate completion date of July 31, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Lupron Depot is a leuprolide acetate-based pharmaceutical product used in hormonal therapies, and this order represents a single delivery transaction under the...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $22,151.50 contract is for the supply of Lupron Depot-Ped 11.25 mg kits, a specialty pharmaceutical product. The delivery order was issued under an indefinite delivery contract and is scheduled to be completed by January 23, 2024. No set-aside designation was used for...
- The Defense Logistics Agency awarded a $7,728.25 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 11.25 mg kits of Lupron Depot-PED. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the requested pharmaceutical products utilizing its corporate office and distribution center located in Conshohocken, Pennsylvania. The ordering period for this contract is August 8-9, 2023. No subcontractors or set aside designations were indicated. The Defense...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $43,385.87, is for the delivery of LUPRON DEPOT-PED 11.25 MG KITS, a specialty medication. The contract is a Firm Fixed Price (FFP) type with a completion date of January 6, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency awarded a $23,004.85 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Lupron Depot-Ped 11.25 mg injections to be administered over a three-month period. The single award was issued against an undisclosed government-wide acquisition contract vehicle or blanket purchase agreement held by Amerisourcebergen. Performance will occur at the prime contractor's facility located in Conshohocken, Pennsylvania by August 18, 2023 to fulfill the Defense...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB25FQMJ2Delivery Order
The Defense Logistics Agency awarded a $23,165.02 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Lupron Depot-Ped 11.25 mg kits. The contract is unclassified as a set-aside and will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 1, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement valued through December 2026 that provides comprehensive pharmaceutical and medical supply support to military healthcare systems worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is well-positioned to fulfill this requirement as a critical federal medical procurement vendor. The company maintains extensive federal contract awards with the Defense Logistics Agency's Medical Supply Chain, supplying a diverse portfolio of pharmaceutical products across multiple therapeutic domains. This delivery order for Lupron Depot-Ped—a pediatric formulation used in endocrinology—aligns with the company's established track record of delivering specialty medications and medical commodities to support Department of Defense healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.2k | 7/31/25 |